Lung Cancer Biomarker Study (BIRD Biobank)
Part of Cancer, Lungs & breathing clinical trials.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have 1 to 3 lung nodules (with at least one larger than 1 cm) seen on a CT scan, or your doctor suspects lung cancer and you need a bronchoscopy, or you already have a confirmed lung cancer diagnosis (any stage).
- You are covered by French social security (or a similar health plan).
- You can understand the study information and sign a consent form (in French).
- You are not pregnant or breastfeeding.
- You are not in prison or under legal guardianship that would prevent you from making your own decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.